FDA approves Novo Nordisk’s diabetes drug Ozempic for chronic kidney disease, expanding its use
The Food and Drug Administration on Tuesday approved Novo Nordisk‘s Ozempic for patients with chronic kidney disease and diabetes, expanding the use of the wildly popular injection in the U.S. The drug is already widely used and covered to treat Type 2 diabetes. The FDA’s decision means Ozempic can now be used to reduce the […]










